Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer. | Elife | 2025 | 40704992 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from Schwann cells to enhance bone and dental tissue regeneration: a literature review. | J Nanobiotechnology | 2025 | 40646600 | PubTator, text mining | PubMed |
| DeepNanoHi-C: deep learning enables accurate single-cell nanopore long-read data analysis and 3D genome interpretation. | Nucleic Acids Res | 2025 | 40637236 | PubTator, text mining | PubMed |
| Temporal dichotomy of neutrophil function in acute liver injury and repair. | JHEP Rep | 2025 | 40606123 | PubTator, text mining | PubMed |
| Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates. | Res Pract Thromb Haemost | 2025 | 40502981 | PubTator, text mining | PubMed |
| Exploring the Potential Regulatory Mechanisms of Mitophagy in Ischemic Cardiomyopathy. | Int J Gen Med | 2025 | 40492232 | PubTator, text mining | PubMed |
| Identification of key genes and signaling pathways of liver cancer and model construction for prognosis and diagnosis based on bioinformatics analysis. | PLoS One | 2025 | 40465781 | PubTator, text mining | PubMed |
| Special Issue: Discovery of Bioactive Phytochemicals' Molecular Mechanisms Against Different Diseases Based on Network Pharmacology and Molecular Docking. | Int J Mol Sci | 2025 | 40429659 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Autoimmunity and Cancer. | Immunotargets Ther | 2025 | 40376194 | PubTator, text mining | PubMed |
| Macrophage-driven exosomes regulate the progression of cardiovascular disease. | Front Pharmacol | 2025 | 40371346 | PubTator, text mining | PubMed |
| Overexpression of LINC00672 promotes autophagy in Alzheimer's disease by upregulating GPNMB. | PLoS One | 2025 | 40367036 | PubTator, text mining | PubMed |
| Mechanisms of Fetal Overgrowth in Gestational Diabetes: The Potential Role of SOCS2. | Nutrients | 2025 | 40362828 | PubTator, text mining | PubMed |
| Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis. | Int J Mol Sci | 2025 | 40243557 | PubTator, text mining | PubMed |
| Correction: SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression. | Cell Death Discov | 2025 | 40199853 | PubTator, text mining | PubMed |
| Identification and validation of mitochondrial endoplasmic reticulum membrane-related genes in atherosclerosis. | Mamm Genome | 2025 | 40148657 | PubTator, text mining | PubMed |
| Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F. | Leukemia | 2025 | 40069287 | PubTator, text mining | PubMed |
| Comparative characterization of human accelerated regions in neurons. | Nature | 2025 | 40011774 | PubTator, text mining | PubMed |
| SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation. | Sci Rep | 2025 | 39922931 | PubTator, text mining | PubMed |
| Molecular simulation of newly designed Mannich-based ciprofloxacin derivative as the promising scaffold for E. coli dihydropteroate synthase and DNA gyrase inhibitor. | J Biomol Struct Dyn | 2025 | 39885801 | PubTator, text mining | PubMed |
| Deciphering the dose-dependent effects of thymoquinone on cellular proliferation and transcriptomic changes in A172 glioblastoma cells. | PLoS One | 2025 | 39874307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=4